Erin Parsons insider trades
Open-market stock purchases and sales by Erin Parsons, Director at Kiora Pharmaceuticals Inc, from SEC Form 4 filings since Nov 30, 2021.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -43%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 10, 2026 | KPRX Kiora Pharmaceuticals Inc | Bought (not open market) | — |